{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:47:44Z","timestamp":1791204464369,"version":"4.2.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fibrogenesis Tissue Repair"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1755-1536-3-5","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T14:14:41Z","timestamp":1272377681000},"source":"Crossref","is-referenced-by-count":66,"title":["Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats"],"prefix":"10.1186","volume":"3","author":[{"given":"Sanne Skovg\u00e5rd","family":"Veidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Vassiliadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gervais","family":"Tougas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"issue":"Suppl 1","key":"20_CR1","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL: Liver fibrosis - from bench to bedside. J Hepatol. 2003, 38 (Suppl 1): S38-S53. 10.1016\/S0168-8278(02)00429-4.","journal-title":"J Hepatol"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1002\/hep.20974","volume":"43","author":"SL Friedman","year":"2006","unstructured":"Friedman SL, Bansal MB: Reversal of hepatic fibrosis - fact or fantasy?. Hepatology. 2006, 43: S82-S88. 10.1002\/hep.20974.","journal-title":"Hepatology"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/138945009788488459","volume":"10","author":"C Balsano","year":"2009","unstructured":"Balsano C, Alisi A, Nobili V: Liver fibrosis and therapeutic strategies: the goal for improving metabolism. Curr Drug Targets. 2009, 10: 505-512. 10.2174\/138945009788488459.","journal-title":"Curr Drug Targets"},{"key":"20_CR4","doi-asserted-by":"crossref","unstructured":"Gressner OA, Weiskirchen R, Gressner AM: Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med. 11: 1031-1051. 10.1111\/j.1582-4934.2007.00092.x.","DOI":"10.1111\/j.1582-4934.2007.00092.x"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cca.2007.02.038","volume":"381","author":"OA Gressner","year":"2007","unstructured":"Gressner OA, Weiskirchen R, Gressner AM: Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta. 2007, 381: 107-113. 10.1016\/j.cca.2007.02.038.","journal-title":"Clin Chim Acta"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-2001-17556","volume":"21","author":"D Schuppan","year":"2001","unstructured":"Schuppan D, Ruehl M, Somasundaram R, Hahn EG: Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis. 2001, 21: 351-372. 10.1055\/s-2001-17556.","journal-title":"Semin Liver Dis"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1155\/2010\/548263","volume":"28","author":"SS Veidal","year":"2010","unstructured":"Veidal SS, Bay-Jensen AC, Tougas G, Karsdal MA, Vainer B: Serum markers of liver fibrosis: combining the BIPED classification and the neo-epitope approach in the development of new biomarkers. Dis Markers. 2010, 28: 15-28.","journal-title":"Dis Markers"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/hep.1840150414","volume":"15","author":"M Shahin","year":"1992","unstructured":"Shahin M, Schuppan D, Waldherr R, Risteli J, Risteli L, Savolainen ER, Oesterling C, Abdel Rahman HM, el Sahly AM, Abdel Razek SM, et al: Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology. 1992, 15: 637-644. 10.1002\/hep.1840150414.","journal-title":"Hepatology"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1373\/clinchem.2006.070466","volume":"52","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S: Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem. 2006, 52: 1815-1817. 10.1373\/clinchem.2006.070466.","journal-title":"Clin Chem"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01606425","volume":"423","author":"A Martinez-Hernandez","year":"1993","unstructured":"Martinez-Hernandez A, Amenta PS: The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch A Pathol Anat Histopathol. 1993, 423: 1-11. 10.1007\/BF01606425.","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2006-927387","volume":"45","author":"C Weiler-Normann","year":"2007","unstructured":"Weiler-Normann C, Herkel J, Lohse AW: Mouse models of liver fibrosis. Z Gastroenterol. 2007, 45: 43-50. 10.1055\/s-2006-927387.","journal-title":"Z Gastroenterol"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/adt.2005.3.553","volume":"3","author":"S Schaller","year":"2005","unstructured":"Schaller S, Henriksen K, Hoegh-Andersen P, Sondergaard BC, Sumer EU, Tanko LB, Qvist P, Karsdal MA: In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?. Assay Drug Dev Technol. 2005, 3: 553-580. 10.1089\/adt.2005.3.553.","journal-title":"Assay Drug Dev Technol"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/13547500902777608","volume":"14","author":"MA Karsdal","year":"2009","unstructured":"Karsdal MA, Henriksen K, Leeming DJ, Mitchell P, Duffin K, Barascuk N, Klickstein L, Aggarwal P, Nemirovskiy O, Byrjalsen I, Qvist P, Bay-Jensen AC, Dam EB, Madsen SH, Christiansen C: Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development. Biomarkers. 2009, 14: 181-202. 10.1080\/13547500902777608.","journal-title":"Biomarkers"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","volume":"55","author":"K Gelse","year":"2003","unstructured":"Gelse K, Poschl E, Aigner T: Collagens - structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003, 55: 1531-1546. 10.1016\/j.addr.2003.08.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/15321810701212088","volume":"28","author":"AM Attallah","year":"2007","unstructured":"Attallah AM, Mosa TE, Omran MM, Abo-Zeid MM, El Dosoky I, Shaker YM: Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV. J Immunoassay Immunochem. 2007, 28: 155-168. 10.1080\/15321810701212088.","journal-title":"J Immunoassay Immunochem"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-2001-17552","volume":"21","author":"RC Benyon","year":"2001","unstructured":"Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis. 2001, 21: 373-384. 10.1055\/s-2001-17552.","journal-title":"Semin Liver Dis"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006, 10: 76-99. 10.1111\/j.1582-4934.2006.tb00292.x.","journal-title":"J Cell Mol Med"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1478-3231.2006.01346.x","volume":"26","author":"Y Osawa","year":"2006","unstructured":"Osawa Y, Seki E, Adachi M, Taura K, Kodama Y, Siegmund SV, Schwabe RF, Brenner DA: Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation. Liver Int. 2006, 26: 1138-1147. 10.1111\/j.1478-3231.2006.01346.x.","journal-title":"Liver Int"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/jbmr.5650020510","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Simon LS, Villanueva AR, Krane SM: Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with Iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res. 1987, 2: 427-436. 10.1002\/jbmr.5650020510.","journal-title":"J Bone Miner Res"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev.bi.64.070195.002155","volume":"64","author":"DJ Prockop","year":"1995","unstructured":"Prockop DJ, Kivirikko KI: Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 1995, 64: 403-434. 10.1146\/annurev.bi.64.070195.002155.","journal-title":"Annu Rev Biochem"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0009-8981(97)00140-X","volume":"266","author":"E Suvanto-Luukkonen","year":"1997","unstructured":"Suvanto-Luukkonen E, Risteli L, Sundstrom H, Penttinen J, Kauppila A, Risteli J: Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy. Clin Chim Acta. 1997, 266: 105-116. 10.1016\/S0009-8981(97)00140-X.","journal-title":"Clin Chim Acta"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1210\/er.21.2.115","volume":"21","author":"SC Manolagas","year":"2000","unstructured":"Manolagas SC: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000, 21: 115-137. 10.1210\/er.21.2.115.","journal-title":"Endocr Rev"},{"key":"20_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","volume":"250","author":"LF Bonewald","year":"1990","unstructured":"Bonewald LF, Mundy GR: Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res. 1990, 250: 261-276.","journal-title":"Clin Orthop Relat Res"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/rheumatology\/39.10.1110","volume":"39","author":"A Scheja","year":"2000","unstructured":"Scheja A, Wildt M, Wollheim FA, Akesson A, Saxne T: Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement. Rheumatology (Oxford). 2000, 39: 1110-1113. 10.1093\/rheumatology\/39.10.1110.","journal-title":"Rheumatology (Oxford)"},{"key":"20_CR25","first-page":"1207","volume":"24","author":"A Pajala","year":"2009","unstructured":"Pajala A, Melkko J, Leppilahti J, Ohtonen P, Soini Y, Risteli J: Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study. Histol Histopathol. 2009, 24: 1207-1211.","journal-title":"Histol Histopathol"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3748\/wjg.15.3516","volume":"15","author":"J George","year":"2009","unstructured":"George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N: Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009, 15: 3516-3522. 10.3748\/wjg.15.3516.","journal-title":"World J Gastroenterol"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10354-008-0594-z","volume":"158","author":"RW Gasser","year":"2008","unstructured":"Gasser RW: Cholestasis and metabolic bone disease - a clinical review. Wien Med Wochenschr. 2008, 158: 553-557. 10.1007\/s10354-008-0594-z.","journal-title":"Wien Med Wochenschr"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00774-007-0833-1","volume":"26","author":"A Mounach","year":"2008","unstructured":"Mounach A, Ouzzif Z, Wariaghli G, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A: Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab. 2008, 26: 379-384. 10.1007\/s00774-007-0833-1.","journal-title":"J Bone Miner Metab"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","volume":"12","author":"A Pares","year":"2008","unstructured":"Pares A, Guanabens N: Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment. Clin Liver Dis. 2008, 12: 407-424. 10.1016\/j.cld.2008.02.005.","journal-title":"Clin Liver Dis"},{"key":"20_CR30","first-page":"281","volume":"15","author":"M Mabuchi","year":"2001","unstructured":"Mabuchi M, Kawamura I, Fushimi M, Inoue T, Takeshita S, Takakura S, Matsuo M, Tomoi M, Goto T: Induction of bone loss by bile duct ligation in rats. In Vivo. 2001, 15: 281-287.","journal-title":"In Vivo"},{"key":"20_CR31","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1023\/A:1005568406664","volume":"45","author":"GR Corazza","year":"2000","unstructured":"Corazza GR, Trevisani F, Di Stefano M, De Notariis S, Veneto G, Cecchetti L, Minguzzi L, Gasbarrini G, Bernardi M: Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis. Dig Dis Sci. 2000, 45: 1392-1399. 10.1023\/A:1005568406664.","journal-title":"Dig Dis Sci"},{"key":"20_CR32","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1053\/jhep.2002.36357","volume":"36","author":"MM Guichelaar","year":"2002","unstructured":"Guichelaar MM, Malinchoc M, Sibonga J, Clarke BL, Hay JE: Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry. Hepatology. 2002, 36: 895-903.","journal-title":"Hepatology"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/ar1152","volume":"6","author":"P H\u00f8egh-Andersen","year":"2004","unstructured":"H\u00f8egh-Andersen P, Tank\u00f3 LB, Andersen TL, Lundberg CV, Mo JA, Heegaard AM, Delaiss\u00e9 JM, Christgau S: Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther. 2004, 6: R169-R180. 10.1186\/ar1152.","journal-title":"Arthritis Res Ther"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00228-006-0174-3","volume":"62","author":"DJ Leeming","year":"2006","unstructured":"Leeming DJ, Alexandersen P, Karsdal MA, Qvist P, Schaller S, Tank\u00f3 LB: An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol. 2006, 62: 781-792. 10.1007\/s00228-006-0174-3.","journal-title":"Eur J Clin Pharmacol"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/00365519950185120","volume":"59","author":"S Schytte","year":"1999","unstructured":"Schytte S, Hansen M, Moller S, Junker P, Henriksen JH, Hillingso J, Teisner B: Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Scand J Clin Lab Invest. 1999, 59: 627-633. 10.1080\/00365519950185120.","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Fibrogenesis & Tissue Repair"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-1536-3-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1755-1536-3-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1755-1536-3-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T18:41:14Z","timestamp":1685558474000},"score":1,"resource":{"primary":{"URL":"https:\/\/fibrogenesis.biomedcentral.com\/articles\/10.1186\/1755-1536-3-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1186\/1755-1536-3-5","relation":{},"ISSN":["1755-1536"],"issn-type":[{"value":"1755-1536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,1]]},"article-number":"5"}}